Dr. Levy has secured the field’s top experts to offer the latest clinical reviews on cholestatic liver disease. The issue will include articles devoted to The Gut-Liver Axis; Update on Genetics in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis; New thoughts on IgG4 Associated Cholangitis; Cancer Risk and Surveillance in PSC; Novel Therapies for PBC; and Liver transplantation for Cholestatic Liver Diseases, to name a few. Dr. Levy’s issue will be the most current authority on cholestatic liver disease.
1. Cover image - p. Cover 2. Title page - p. Cover 3. Table of Contents - p. Cover 4. Copyright - p. Cover 5. Contributors - p. Cover 6. Forthcoming Issues - p. Cover 7. Preface. Advances in Cholestatic Liver Diseases - p. Cover 8. The Gut-Liver Axis in Primary Sclerosing Cholangitis - p. Cover 9. The Immunogenetics of Autoimmune Cholestasis - p. Cover 10. Making Sense of Autoantibodies in Cholestatic Liver Diseases - p. Cover 11. New Thoughts on Immunoglobulin G4–Related Sclerosing Cholangitis - p. Cover 12. Primary Sclerosing Cholangitis: Multiple Phenotypes, Multiple Approaches - p. Cover 13. Cancer Risk and Surveillance in Primary Sclerosing Cholangitis - p. Cover 14. Sclerosing Cholangitis in Children and Adolescents - p. Cover 15. Novel Therapies on Primary Biliary Cirrhosis - p. Cover 16. Understanding and Treating Fatigue in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis - p. Cover 17. Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver Diseases - p. Cover 18. Total Parenteral Nutrition–Induced Cholestasis: Prevention and Management - p. Cover 19. New Insights on Intrahepatic Cholestasis of Pregnancy - p. Cover 20. Liver Transplantation for Cholestatic Liver Diseases in Adults - p. Cover
Dr. Levy has secured the field’s top experts to offer the latest clinical reviews on cholestatic liver disease. The issue will include articles devoted to The Gut-Liver Axis; Update on Genetics in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis; New thoughts on IgG4 Associated Cholangitis; Cancer Risk and Surveillance in PSC; Novel Therapies for PBC; and Liver transplantation for Cholestatic Liver Diseases, to name a few. Dr. Levy’s issue will be the most current authority on cholestatic liver disease.
1. Cover image - p. Cover 2. Title page - p. Cover 3. Table of Contents - p. Cover 4. Copyright - p. Cover 5. Contributors - p. Cover 6. Forthcoming Issues - p. Cover 7. Preface. Advances in Cholestatic Liver Diseases - p. Cover 8. The Gut-Liver Axis in Primary Sclerosing Cholangitis - p. Cover 9. The Immunogenetics of Autoimmune Cholestasis - p. Cover 10. Making Sense of Autoantibodies in Cholestatic Liver Diseases - p. Cover 11. New Thoughts on Immunoglobulin G4–Related Sclerosing Cholangitis - p. Cover 12. Primary Sclerosing Cholangitis: Multiple Phenotypes, Multiple Approaches - p. Cover 13. Cancer Risk and Surveillance in Primary Sclerosing Cholangitis - p. Cover 14. Sclerosing Cholangitis in Children and Adolescents - p. Cover 15. Novel Therapies on Primary Biliary Cirrhosis - p. Cover 16. Understanding and Treating Fatigue in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis - p. Cover 17. Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver Diseases - p. Cover 18. Total Parenteral Nutrition–Induced Cholestasis: Prevention and Management - p. Cover 19. New Insights on Intrahepatic Cholestasis of Pregnancy - p. Cover 20. Liver Transplantation for Cholestatic Liver Diseases in Adults - p. Cover
